Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

09/11/2022 06:30

Nov 9 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.96                9.57             19.36    
                 (+4.2 pct)          (+14.4 pct)      (+1.3 pct)  
  Operating        492 mln             777 mln            1.17    
                 (-36.6 pct)        (+110.9 pct)      (-24.2 pct) 
  Recurring        589 mln             820 mln            1.11    
                 (-28.2 pct)        (+118.1 pct)      (-30.8 pct) 
  Net              258 mln             457 mln          714 mln   
                 (-43.6 pct)        (+103.1 pct)      (-31.5 pct) 
  EPS             77.37 yen          134.13 yen       213.01 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T